Reprogramming ligand-receptor interactions via a self-powered molecular engine for proton-responsive regulation of cellular motility.

Authors

Yang Li, Hui Wang, Guofang Zhang, Yanfang Wang, Qian Hou, Zhibin Zhao, Lili Zhang, Sai Bi

Published in

Biosensors & bioelectronics. Volume 312. Pages 119084. Jul 30, 2026. Epub Jul 30, 2026.

Abstract

Manipulation of ligand-receptor interactions (LRIs) in a user-defined manner is one of the effective ways to regulate cell motility and disease progression. Molecular engines orchestrate LRIs to regulate cell motility by harnessing various forms of energy within physiological surroundings. However, engineering chemical engines remains largely unexplored, primarily due to the insufficient chemical cue density, uncertain conformational changes of scaffolds, and a limited repertoire of environment-responsive switchable scaffolds. Enzymatic biofuel cells (EBFCs) are electrochemical devices that convert biofuels into other accessible energy through electrochemical reaction for the construction of self-powered molecular tools, offering a viable strategy to overcome the above limitations. Here, we present an enzyme biofuel cell-based self-powered molecular engine (EBFC-SME) for rewiring chemical cues-based LRIs and regulating cell motility. We employ EBFC-SME as a proof-of-concept platform for reprogramming proton-responsive HGF/c-Met interaction. The system comprises a glucose dehydrogenase (GDH)-incorporated bioanode and a bilirubin oxidase (BOD)/functional nucleic acids (FNAs)-encapsulated iron-alginate (IA) hydrogel-coated biocathode. Through glucose-initiated redox reactions, this configuration enables the EBFC-SME to generate abundant protons and release FNAs. These products subsequently mediate the in-situ assembly on tumor cell membrane, which blocks c-Met pathway activation and ultimately suppresses tumor cell migration. Different from conventional chemical engines, the EBFC-SME efficiently regenerates chemical cues via intrinsic energy conversion reactions for the manipulation of scaffold-mediated LRIs. This EBFC-SME platform provides a robust "sensing-conversion-initiation" tool for the chemical regulation of cellular motility, holding significant promise in precision biomedicine.

PMID:
42546385
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.